Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) in adults in refractory cardiac arrest Interventional procedure consultation ...

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over TA1054 15 April 2025 15 April 2025 ...

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B HST32 2 April 2025 2 April 2025 Efanesoctocog alfa for treating and preventing bleeding episodes ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Molnupiravir is recommended as an option for treating mild to moderate COVID‑19 in adults who have a positive SARS‑CoV‑2 test, only if: they have 1 or more risk factors for progression to severe COVID ...

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations. NICE has separately evaluated cladribine for highly active multiple sclerosis in NICE ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

We've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer that ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures. Babies and ...